Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DNA study sheds light on diabetes risk
belgian shepherd
Researchers analysed the DNA of more than 500 healthy dogs to find out if genetic factors influence the variation of fructosamine levels in the blood.

Genetic interaction in Belgian shepherd dogs could protect against diabetes

Scientists have discovered a genetic interaction that could explain why Belgian shepherd dogs have a lower risk of developing diabetes.

An interaction between genes located on two different chromosomes provides a novel mechanism for regulating blood-sugar levels, according to research published in the PLOS ONE journal.

Diabetes is a serious health problem in both dogs and humans. Some dog breeds, including various spaniels and terriers, have an increased risk of developing the condition, whilst others are very rarely affected.

"The Belgian shepherd breed has a low risk of developing diabetes and our findings could be connected to a protective mechanism against the disease," explained Dr Marcin Kierczak from Uppsala University. "Now we are trying to learn more about this phenomenon."

Researchers from the Swedish University of Agricultural Sciences and Uppsala University analysed the DNA of more than 500 healthy dogs of nine different breeds, from five European countries, to find out if genetic factors influence the variation of fructosamine levels in the blood.

Measuring the concentration of fructosamine in the blood is one way to diagnose and monitor diabetes, as it indicates the blood-sugar level over a period of time.

Analysing the breeds separately, the research team found variations in part of chromosome 3 that link to fructosamine concentrations in Belgian shepherds of the Malinois subtype. Within and close to this area, they discovered interesting candidate genes that have previously been associated with glucose metabolism.

After further study, researchers found a region of chromosome 5 that interacts with the part of chromosome 3 they had already identified. However, the mechanism by which these genes interact remains to be discovered.

"Dogs need a good oxygen supply and an even blood-sugar level to work hard," said lead author Katja Höglund. "Our hypothesis is that dogs with good blood glucose control have been selected in the course of developing the Belgian shepherd, thus creating a breed with a protective trait against development of diabetes."

It is thought further investigation could improve the diagnosis and treatment of diabetes.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.